Hofseth Biocare ASA operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hofseth Biocare ASA with three other
pharmaceutical manufacturers in Europe:
sales of 661.34 million Russian Rubles [US$11.67 million]
MPH Health Care AG
(47,325.96 Euro [US$57,644.44 ]
based in the United Kingdom
(£164,784.00 [US$226,352.25 ]
of which 100%
was Pharmaceutical Research & Development).
During the year ended December of 2016, sales at
Hofseth Biocare ASA were NOK 20.20 million (US$2.55 million).
decrease of 37.1%
versus 2015, when the company's sales were NOK 32.14 million.
Contributing to the drop in overall sales was the 88.0% decline
in By-Products, from NOK 11.73 million to NOK 1.41 million.
There were also decreases in sales in
Soluble Protein (down 39.9% to NOK 5.18 million)
Calcium (down 70.3% to NOK 27,000.00 )
However, these declines were partially offset by the increase in sales of
Salmon Oil (up 16.1% to NOK 13.59 million)